Published online Nov 15, 2022. doi: 10.4251/wjgo.v14.i11.2138
Peer-review started: July 9, 2022
First decision: July 31, 2022
Revised: August 30, 2022
Accepted: October 31, 2022
Article in press: October 31, 2022
Published online: November 15, 2022
Processing time: 128 Days and 16.4 Hours
Human sine oculis homeobox homolog (SIX) protein belongs to the homeobox family, which plays an important role in different developmental organs, and the abnormal expression of most development-related genes is closely related to the occurrence and development of malignant tumors. However, no studies have comprehensively analyzed SIXs in colorectal cancer (CRC).
SIXs has been found to be closely related to the occurrence and development of cancer. However, there are few studies on SIXs in CRC. SIXs may become a new potential prognostic indicator of CRC.
To comprehensively analyze the expression and the prognosis of the SIX family in CRC tissues and to explore the potential role of the SIX family as a new prognostic indicator of CRC.
In this study, the RNA and protein expression levels of the SIX family in CRC were analyzed by various online databases and immunohistochemically. Then the relationship between the SIX family and the prognosis of CRC was further analyzed. In order to better understand the mechanism of SIX4, the positive correlation between SIX4 expression and tumor-node-metastasis stage of CRC was analyzed. Then, the relationship between SIX4 mRNA levels and clinicopathological parameters in CRC patients was analyzed.
The expression levels of SIXs in most organs were relatively low in the Human Protein Atlas. UCSC Xena database analysis showed that the expression levels of SIX1, SIX2 and SIX4 in CRC were higher than those in corresponding normal tissue. Further survival analysis with Kaplan-Meier Plotter showed that the relation between poor overall survival and disease-free survival of CRC patients and high SIX4 expression were significant. Using the LinkedOmics database, the expression of SIX4 was positively correlated with the clinical stage, T stage and N stage of CRC, and the top 50 SIX4-related genes were involved in oxidative phosphorylation and respiratory chain signaling pathway, suggesting that SIX4 was involved in promoting the growth and metastasis of CRC.
As a member of the SIX family, SIX4 played a role in promoting tumor development in the intestine, which may serve as a potential prognostic indicator and therapeutic target for CRC patients. Therefore, targeting SIX4 may serve as a new therapeutic strategy for CRC patients, providing important potential for the treatment of CRC.
This is the first comprehensive analysis of the potential role and prognostic value of the SIX family in CRC. However, the current research is limited, and future studies need to further explore the oxidative phosphorylation, respiratory chain activity and metabolism of SIX4 in CRC.